Condition: Asthma
Intervention:
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Recruiting – verified November 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Airway Response to Repeat Allergen Challenge and the Effect of Ibuprofen in Mild Atopic Asthma
Condition: Atopic Asthma
Interventions: Drug: ibuprofen; Drug: Placebo
Sponsor: University of Saskatchewan
Recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects
Condition: Respiratory Disorders
Interventions: Drug: Reference Montelukast; Drug: Test 1 Montelukast; Drug: Test 2 Montelukast
Sponsor: GlaxoSmithKline
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
Condition: Asthma
Interventions: Biological: Benralizumab; Biological: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes
Condition: Asthma
Interventions: Behavioral: CAPE; Behavioral: Home
Sponsors: University of Illinois at Chicago; Sinai Health System; Cook County Health & Hospitals System; Rush University Medical Center; Ann & Robert H Lurie Children’s Hospital of Chicago; University of Chicago; Chicago Department of Public Health; Respiratory Health Association; Chicago Asthma Consortium; Illinois Institute of Technology; Illinois Emergency Department Asthma Surveillance Project; Patient Centered Outcome Research Institute
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
AMP-BPT and His-BPT for Assessment of Asthma
Condition: Asthma
Intervention: Drug: inhaled corticosteroids (usually budesonide/fomorterol 160/4.5mcg; fluticasone/salmeterol 250/50mcg)
Sponsor: Guangzhou Institute of Respiratory Disease
Completed – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation
Conditions: Myeloproliferative Neoplasm; Primary Myelofibrosis; Essential Thrombocythemia; Polycythemia Vera
Intervention: Drug: Mirabegron
Sponsor: Swiss Group for Clinical Cancer Research
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Supporting Asthma Management Behaviors in Aging Adults
Condition: Asthma
Intervention: Behavioral: Supporting Asthma Management Behaviors in Aging Adults (SAMBA)
Sponsor: Mount Sinai School of Medicine
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
The Childhood Health and Asthma Management Program
Conditions: Asthma; Obesity; Family; Child
Interventions: Behavioral: CHAMP; Behavioral: Health education
Sponsors: University of Florida; American Lung Association
Recruiting – verified November 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product
Condition: Asthma
Interventions: Drug: Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh; Drug: Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh; Drug: Symbicort Turbuhaler 320/9 ug/inhalation 4 inh; Drug: Symbicort Turbuhaler 320/9 ug/inhalation 1inh; Drug: Placebo Symbicort Turbuhaler 320/9 ug/inhalation 4 inh; Drug: Placebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh; Drug: Placebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh; Drug: Placebo Symbicort Turbuhaler 320/9 ug/inhalation 1 inh
Sponsor: Orion Corporation, Orion Pharma
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days